Pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015, the Board of Directors of the Company in its meeting held on Wednesday, 28th May, 2025 at 04:30 P.M at the corporate office of the company at 703, Arunachal Building, 19, Barakhamba Road, Connaught Place, New Delhi - 110001 and concluded at 6 : 10 P.M has considered and approved the Standalone Audited Financial Results of the Company alongwith Auditor's Report for the Standalone Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2025.

pdf

MPS Pharma Ltd.

19 May 2025

2.72

-4.90%

Board Meeting

Advik Laboratories Ltd - 531686 - Board Meeting Intimation for Calling A Meeting Of The Board …

BSE India

Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2025 ,inter alia, to consider and approve 1. To consider and approve the Audited Financial Results of the Company for the quarter and Financial Year ended 31st March, 2025. 2. To consider the appointment of M/s Sanghi & Co., Chartered Accountants as the Internal Auditor of the Company for the F.Y. 2025-26. 3. To carry on any other business with the permission of the Board.

pdf

MPS Pharma Ltd.

30 Apr 2025

2.72

-4.90%

Company Update

Advik Laboratories Ltd - 531686 - Confirmation On Non Applicability Of The Criteria Specified Under SEBI …

BSE India

PFA the confirmation w.r.t. the non-applicability of the SEBI Circulars as mentioned in the captioned subject for the F.Y. 2024-25

pdf

Is Advik Laboratories Ltd. worth buying?

5 Votes:

Buy 40.0%

Sell 20.0%

Hold 40.0%